Dr. Reddy's Laboratories Ltd (RDY) Ex-Dividend Date Scheduled for July 10, 2013

By
A A A

Dr. Reddy's Laboratories Ltd ( RDY ) will begin trading ex-dividend on July 10, 2013. A cash dividend payment of $0.2644 per share Shareholders who purchased RDY stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 15.26% increase over the prior year.

The previous trading day's last sale of RDY was $36.77, representing a -5.09% decrease from the 52 week high of $38.74 and a 28.03% increase over the 52 week low of $28.72.

RDY is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). RDY's current earnings per share, an indicator of a company's profitability, is $1.9. Zacks Investment Research reports RDY's forecasted earnings growth in 2014 as 10.81%, compared to an industry average of -7.5%.

For more information on the declaration, record and payment dates, visit the RDY Dividend History page.

Interested in gaining exposure to RDY through an Exchange Traded Fund [ETF]?
The following ETF(s) have RDY as a top-10 holding:

  • EGShares Health Care GEMS ETF ( HGEM )
  • First Trust Exchange-Traded Fund II First Trust BICK Index Fun ( BICK ).

The top-performing ETF of this group is HGEM with an increase of 4.71% over the last 100 days. It also has the highest percent weighting of RDY at 4.95%.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , Stocks

Referenced Stocks: BICK , HGEM , JNJ , PFE , RDY

NASDAQ.com News

NASDAQ.com News

More from NASDAQ.com News:

Related Videos

Stocks

Referenced

Most Active by Volume

111,864,163
  • $3.91 ▲ 2.36%
76,404,746
  • $7.37 ▼ 5.03%
66,680,057
  • $15.25 ▼ 2.12%
61,293,760
  • $30.55 ▼ 6.09%
56,394,825
    $23 unch
55,005,642
  • $95.60 ▼ 2.60%
47,372,853
  • $95.02 ▼ 2.02%
44,783,481
  • $45.19 ▼ 2.40%
As of 7/31/2014, 04:07 PM